Replicel at this juncture is a waste of time.. If you want RCH look to shiseido. Replicel has no money intended to be used to develop RCH any further. They will wait entirely for Shiseido to conduct its trial. If Shiseidos trial is effective then other companies will look to snatch this technology up from replicel to be used in EU and USA/CAN.. pending legal policy changes creating a favorable stem cell/ regenerative medicine environment.
Replicel staff is loading us up with false promises, we must look to the East and hope for Japan/Shiseido.
04-22-2016 03:00 PM
michaelgranger65
Tomtom21, I think you are spot on about focusing on Shiseido for any advancements with RCH. Replicel recently slimmed down their operational costs - likely to stay solvent and preserve cash flow. Actually that isn't speculation, they had a release stating as much. Shiseido has a trial scheduled this year but it's hard to know if it has started yet because all of their Phase 2 trial websites are only in Japanese. I do know that they built or at least retrofitted a facility specifically to conduct this 20 month trial. It isn't just a safety trial either. It is designed to pass their new laws for early commercial release. Replicel is working on other product lines and revenue streams since Shiseido is in a much better position to advance this treatment... and I believe that's a very good thing.
So the damn trials haven't started yet??? Hurry up people
07-11-2016 12:42 PM
michaelgranger65
I apologize in advance if posting other websites is not permitted here. However, it looks like we'll have both Replicel/Shiseido (Japan) and Histogen (Mexico) releases scheduled for sometime in 2018. We've had speculation on release dates for several years now. However, given all the groundwork that has been done so far I'm cautiously optimistic that one of these products will on the market by 2018. Pricing is included on both links and I won't spoil the read. Enjoy
